446
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Felipe Castillo, Daniel Scalise, David Hernandez, Rahul Gupta, Cale N. Basaraba, Thomas Corbeil, Sandra D. Comer & Andres R. Schneeberger. (2023) Preliminary attitudes on medications for opioid use disorders (MOUDs) in Southeastern Switzerland and New York City. Journal of Addictive Diseases 41:1, pages 91-97.
Read now
A. Taylor Kelley, Michael A. Incze, Jacob D. Baylis, Spencer G. Calder, Saul J. Weiner, Susan L. Zickmund, Audrey L. Jones, Megan E. Vanneman, Molly B. Conroy, Adam J. Gordon & John F.P. Bridges. (2022) Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Substance Abuse 43:1, pages 1286-1299.
Read now

Articles from other publishers (12)

Rachel P. Winograd, Bridget Coffey, Melissa Nance & Ryan Carpenter. (2023) The association of medical providers’ attitudes about naloxone and treating people with opioid use disorder and their self-reported low-barrier treatment practices. Addictive Behaviors Reports 18, pages 100514.
Crossref
A. Taylor Kelley, Jordynn Wilcox, Jacob D. Baylis, Norah L. Crossnohere, John Magel, Audrey L. Jones, Adam J. Gordon & John F. P. Bridges. (2022) Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. Journal of General Internal Medicine 38:9, pages 2147-2155.
Crossref
Rita Tabanelli, Simone Brogi & Vincenzo Calderone. (2023) Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?. International Journal of Molecular Sciences 24:13, pages 10888.
Crossref
Erin F. Madden, Kristin K. Barker, Joshua Guerra, Corey Villanueva & Sandra H. Sulzer. (2022) Variation in intervention stigma among medications for opioid use disorder. SSM - Qualitative Research in Health 2, pages 100161.
Crossref
P.J. Davidson, J.M. Bowles, M. Faul & T.L. Gaines. (2022) Spatial proximity and access to buprenorphine or methadone treatment for opioid use disorder in a sample of people misusing opioids in Southern California. Journal of Substance Abuse Treatment 132, pages 108634.
Crossref
Ilkka Ojanperä, Claudia Mariottini & Pirkko Kriikku. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 2863 2882 .
Ilkka Ojanperä, Claudia Mariottini & Pirkko Kriikku. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 20 .
Rajoo Saroj, Abhishek Ghosh, BN Subodh, Ritu Nehra, Tathagata Mahintamani, Devender K. Rana & Debasish Basu. (2020) Neurocognitive functions in patients on buprenorphine maintenance for opioid dependence: A comparative study with three matched control groups. Asian Journal of Psychiatry 53, pages 102181.
Crossref
Bertha K. Madras, N. Jia Ahmad, Jenny Wen & Joshua Sharfstein. (2020) Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System. NAM Perspectives.
Crossref
Kirsten E. Smith, Martha D. Tillson, Michele Staton & Erin M. Winston. (2020) Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky. Drug and Alcohol Dependence 208, pages 107837.
Crossref
Rebecca L Haffajee & Cecelia A French. (2019) Provider perceptions of system-level opioid prescribing and addiction treatment policies. Current Opinion in Psychology 30, pages 65-73.
Crossref
Hannah K. Knudsen, Michelle R. Lofwall, Lewei Allison Lin, Sharon L. Walsh & Jamie L. Studts. (2019) US physicians’ decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progress. Drug and Alcohol Dependence 204, pages 107490.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.